THE WHAT? Akums Medication and Prescribed drugs has agreed to amass the manufacturing enterprise of Oriflame India for ₹56 crore, marking its entry into the color cosmetics manufacturing sector and increasing its contract manufacturing capabilities past prescription drugs.
THE DETAILS The acquisition, by means of Akums’ wholly owned subsidiary Pure and Remedy Healthcare, contains manufacturing amenities in Roorkee and Noida, along with a leased warehouse in Noida. The websites manufacture skincare, hair care, wellness and color cosmetics merchandise, and are geared up with European manufacturing gear and Halal-certified amenities that assist export alternatives. The transaction excludes Oriflame India’s logos, advertising and gross sales operations, with completion anticipated by the top of August, topic to customary circumstances.
THE WHY? The deal displays rising funding in India’s cosmetics manufacturing sector as contract improvement and manufacturing organisations (CDMOs) diversify into higher-growth magnificence classes. It additionally allows Akums to strengthen its manufacturing capability for each home and worldwide magnificence manufacturers whereas increasing its place within the skincare, hair care and color cosmetics provide chain.
Supply: Financial Instances
